Clinical trial
Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In…
NCT00470236 · Trans Tasman Radiation Oncology Group, Other · Unknown status
Key facts
| NCT number | NCT00470236 |
|---|---|
| Title | Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast |
| Official title | A Randomised Phase III Study of Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast |
| Acronym | DCIS |
| Lead sponsor | Trans Tasman Radiation Oncology Group, Other |
| Collaborators | Breast International Group NCIC Clinical Trials Group Cancer Trials Ireland Borstkanker Onderzoek Groep ETOP IBCSG Partners Foundation Scottish Cancer Trials Breast Group European Organisation for… |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Carcinoma, Ductal, Breast |
| Intervention type | Radiation |
| Interventions | Standard WB fractionation, Shorter WB fractionation, Standard WB fractionation+Boost, Shorter WB fractionation + Boost |
| Enrollment | 1,608 |
| Start date | Jun 1, 2007 |
| Primary completion | Jun 1, 2024 |
| Completion | Jun 1, 2024 |
| First posted | May 7, 2007 |
| Last update posted | Mar 22, 2023 |
| Countries | Australia, Belgium, Canada, France, Ireland, Italy, Netherlands, New Zealand, Singapore, Switzerland, United Kingdom |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: